Question

I am a breastfeeding mother and i want to know if it is safe to use CCRIS 3404? Is CCRIS 3404 safe for nursing mother and child? Does CCRIS 3404 extracts into breast milk? Does CCRIS 3404 has any long term or short term side effects on infants? Can CCRIS 3404 influence milk supply or can CCRIS 3404 decrease milk supply in lactating mothers?

CCRIS 3404 lactation summary

CCRIS 3404 is dangerous in breastfeeding
  • DrLact safety Score for CCRIS 3404 is 7 out of 8 which is considered Dangerous as per our analyses.
  • A safety Score of 7 indicates that usage of CCRIS 3404 may cause toxic or severe side effects in breastfed baby.
  • Our study of different scientific research indicates that CCRIS 3404 may cause moderate to high side effects or may affect milk supply in lactating mother.
  • Our suggestion is to use safer alternate options rather than using CCRIS 3404 .
  • Usage of CCRIS 3404 is in contradiction to breastfeeding hence if it is must to use CCRIS 3404 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About CCRIS 3404 usage in lactation

Resuming breastfeeding is likely safe when milk platinum levels are not detected (30 days).

Answer by DrLact: About CCRIS 3404 usage in lactation

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as CCRIS 3404.[1] It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence, but the duration of abstinence is not clear. In one case, CCRIS 3404 was still detectable in milk 13 days after a dose of 2.9 mg/kg. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[2]Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[3]

Alternate Drugs

Imatinib(Unsafe)
Thioguanine(Dangerous)
Erlotinib(Unsafe)
Cladribine(Dangerous)
Letrozole(Dangerous)
Exemestane(Dangerous)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Cetuximab(Unsafe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Doxorubicin(Dangerous)
Gemcitabine(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.